Cambridge Acquisition, a blank check company targeting the technology sector, filed on Monday with the SEC to raise up to $200 million in an initial public offering.
The company plans to raise $200 million by offering 20 million units at $10.00. Each unit consists of one share of common stock and one-third of one warrant exercisable at $11.50.
Cambridge Acquisition is led by Chairman Michael Cam-Phung, the VP and Head of Medtech Solutions Strategy at Tekni-Plex. He is joined by CEO and Director Brent Cox, the founder and Managing Principal of private investment firm Subtext Holdings, and CFO Anthony Naimo, the Managing Director of management consulting firm Procorso and CFO of Sarah Flint.
The SPAC plans to target businesses in the technology industry, particularly companies operating in sectors such as harm-reduction, wellness-oriented products, hemp-derived or functional botanical consumables, psychedelics, health-oriented markets, or technology-enabled platforms.
The Boston, MA-based company was founded in 2025 and plans to list on the Nasdaq under the symbol CAQU. BTIG is the sole bookrunner on the deal.
